Skip to content

The Translational Initiative to Map Epigenetics in Aging (TIME-A)

The Translational Initiative to Map Epigenetics in Aging (TIME-A)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05760547
Acronym
TIME-A
Enrollment
25000
Registered
2023-03-08
Start date
2023-03-08
Completion date
2033-03-31
Last updated
2023-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biological Aging

Brief summary

The Translational Initiative to Map Epigenetics in Aging (TIME-A) study aims to advance our understanding of the connections between epigenetics, lifestyle, demographics, and health and aging.

Detailed description

TIME-A is a longitudinal research initiative. Anyone who has ever taken an Index test registered through Elysium Health is eligible to participate. Participation involves answering questions that will be administered via a survey format. Research participants' survey responses will be combined with their epigenetic Index data with the primary aim of identifying the contributions of 1) environmental and lifestyle factors, 2) general health, and 3) medical history, on biological age. Exploratory aims include the development of epigenetic signatures that are predictive of health status, and exploring the relationship between epigenetically-derived health phenotypes and biological age. These findings will lay the foundation for personalized health recommendations using Index (including, but not limited to: workout routines, diets, supplement regimens, medications, lifestyle changes).

Interventions

None listed

Sponsors

Elysium Health
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All adults aged 18 and above * Have registered at least one Index kit via the Elysium Health website * Able and willing to provide digital consent to the Research Consent Form, and the TIME-A Research Subject Consent Form

Exclusion criteria

* Consent to participate not given

Design outcomes

Primary

MeasureTime frameDescription
Effect of environmental and lifestyle factors on biological ageAt baseline and throughout study (approximately every 6 months up to 120 months)Univariate and multivariate statistical methods will be used to identify which environmental and lifestyle factors (from TIME-A survey responses) influence biological age.
Effect of general health on biological ageAt baseline and throughout study (approximately every 6 months up to 120 months)Univariate and multivariate statistical methods will be used to identify which general health characteristics (from TIME-A survey responses) influence biological age.
Effect of medical history on biological ageAt baseline and throughout study (approximately every 6 months up to 120 months)Univariate and multivariate statistical methods will be used to identify the impact of medical history (from TIME-A survey responses) on biological age.

Other

MeasureTime frameDescription
Develop epigenetic signatures that are predictive of health statusAt baseline and throughout study (approximately every 6 months up to 120 months)DNA methylation data and TIME-A survey responses will be combined. Supervised and unsupervised machine learning methods will be used to generate novel methylation-derived predictors of participants' survey responses.

Contacts

Primary ContactRyan Dellinger, PhD
care@elysiumhealth.com(888) 220 6436

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026